CytoDyn (CYDY) Retained Earnings (2011 - 2026)
CytoDyn (CYDY) posted Retained Earnings of $815.0 million for Q1 2026, up 188.98% on a QoQ basis from -$915.9 million in Q4 2025, and up 3.47% year-over-year from $787.6 million in Q1 2025.
CytoDyn (CYDY) Retained Earnings (2011 - 2026) Analysis & Trends
CytoDyn's Retained Earnings history runs 16 years deep, the most recent figure standing at $815.0 million for Q1 2026.
- Quarterly Retained Earnings rose 3.47% year-over-year to $815.0 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $815.0 million (up 3.47% YoY) and the FY2025 annual result came in at $790.5 million, up 2.17% from the prior year.
- Retained Earnings was $815.0 million for Q1 2026 at CytoDyn, up from -$915.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $815.0 million in Q1 2026 and bottomed at -$915.9 million in Q4 2025.
- A 5-year average of -$81.9 million and a median of -$782.9 million in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 221.19% in 2022, while the deepest fall reached 236.48% in 2022.
- CytoDyn's Retained Earnings stood at -$809.4 million in 2022, then jumped by 192.35% to $747.5 million in 2023, then increased by 5.22% to $786.5 million in 2024, then plunged by 216.46% to -$915.9 million in 2025, then surged by 188.98% to $815.0 million in 2026.
- Business Quant data shows CYDY's Retained Earnings at $815.0 million in Q1 2026, -$915.9 million in Q4 2025, and $792.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | 814.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 814.98 Mn |
| Nov 30, 2025 | -915.93 Mn |
| Aug 31, 2025 | 792.56 Mn |
| May 31, 2025 | 790.50 Mn |
| Feb 28, 2025 | 787.62 Mn |
| Nov 30, 2024 | 786.46 Mn |
| Aug 31, 2024 | -872.30 Mn |
| May 31, 2024 | 773.71 Mn |
| Feb 29, 2024 | -874.70 Mn |
| Nov 30, 2023 | 747.47 Mn |
| Aug 31, 2023 | -853.30 Mn |
| May 31, 2023 | -841.69 Mn |
| Feb 28, 2023 | -823.10 Mn |
| Nov 30, 2022 | -809.35 Mn |
| Aug 31, 2022 | -782.86 Mn |
| May 31, 2022 | 671.01 Mn |
| Feb 28, 2022 | -782.90 Mn |
| Nov 30, 2021 | -639.94 Mn |
| Aug 31, 2021 | 573.60 Mn |
| May 31, 2021 | -553.68 Mn |